ENTITY
Voronoi

Voronoi (310210 KS)

14
Analysis
Health Care • South Korea
Voronoi, Inc. operates as a drugs development company. The Company develops and manufactures kinase inhibitor and other new drugs. Voronoi provides services in Korea.
more
•31 Aug 2022 14:24

End of Mandatory Lock-Up Periods for 40 Companies in Korea in September 2022

We discuss end of the mandatory lock-up periods for 40 stocks in Korea in September 2022. These 40 stocks on average could be subject to further...

Logo
408 Views
Share
•17 Dec 2025 07:10

KRX Short Interest Weekly (Dec 12th): SANIL ELECTRIC, Hanwha Vision, Kakaopay, Samsung F&M Insurance

We analyzed KRX short interest report for the past week and highlighted short interest changes in SANIL ELECTRIC, Hanwha Vision, kakaopay, Samsung...

Logo
281 Views
Share
•23 Nov 2023 18:52

KOSDAQ150 Index Rebalance: 17 Changes a Side; Many Surprises

There are 17 changes a side for the KOSDAQ150 in Dec. Most of the inclusions were on expected lines, but there are many difference among the...

Logo
782 Views
Share
bullish•Celltrion Inc
•02 Nov 2023 05:40

Celltrion Merger: Appraisal Rights & Passive Flows

The appraisal rights exercise period ends 13 Nov. Both companies are buying back shares. The last traded price is close to the appraisal price....

Logo
676 Views
Share
•29 Oct 2023 05:19

Index Rebalance & ETF Flow Recap: KS200, KQ150, Yuanta Div+, LIT, HSCI, IDX, Japan Positioning

This recap highlights Insights covering Asian index rebalances (announcements/ forecasts/ IPO Fast Entry/ M&A driven changes). We also highlight...

Logo
1k Views
Share
x